InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,279.21
(
-0.51%
)
US TECH 100
18,280.40
(
-0.58%
)
Dow Jones
38,497.10
(
-0.92%
)
Brent Oil
83.52
(
-0.95%
)
Bitcoin
67,548.63
(
-1.09%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: kld2 post# 38431

Thursday, 02/23/2017 5:19:52 PM

Thursday, February 23, 2017 5:19:52 PM

Post# of 48316
All 22 patients in the $ONCS combo trial had a very low of <22 TIL. They are all nonresponders based on $ONCS diagnosis. Of the 22 patients, 9 had been previously treated with, in "OTHER TRIALS" , checkpoint inhibitors therapy with obvious zero response.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM

One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM

Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM

HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!